Ann M. Leen

10.4k total citations
165 papers, 7.2k citations indexed

About

Ann M. Leen is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Ann M. Leen has authored 165 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Oncology, 82 papers in Immunology and 76 papers in Epidemiology. Recurrent topics in Ann M. Leen's work include CAR-T cell therapy research (83 papers), Cytomegalovirus and herpesvirus research (68 papers) and Virus-based gene therapy research (65 papers). Ann M. Leen is often cited by papers focused on CAR-T cell therapy research (83 papers), Cytomegalovirus and herpesvirus research (68 papers) and Virus-based gene therapy research (65 papers). Ann M. Leen collaborates with scholars based in United States, Netherlands and United Kingdom. Ann M. Leen's co-authors include Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Catherine M. Bollard, Juan F. Vera, Adrian P. Gee, Ulrike Gerdemann, Stephen Gottschalk, Robert A. Krance and Aaron E. Foster and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ann M. Leen

162 papers receiving 7.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann M. Leen United States	46	4.9k	2.8k	2.5k	2.5k	1.3k	165	7.2k
M. Helen Huls United States	27	3.9k 0.8×	2.4k 0.9×	1.0k 0.4×	1.2k 0.5×	774 0.6×	48	4.9k
Chiara Bonini Italy	48	5.8k 1.2×	4.0k 1.4×	863 0.3×	3.3k 1.3×	3.6k 2.8×	180	10.7k
Richard A. Morgan United States	44	4.8k 1.0×	2.8k 1.0×	725 0.3×	2.5k 1.0×	2.7k 2.1×	112	7.4k
Ulrike Koehl Germany	45	2.9k 0.6×	3.0k 1.1×	761 0.3×	757 0.3×	1.3k 1.0×	155	5.6k
Simon F. Lacey United States	50	11.9k 2.4×	4.5k 1.6×	1.1k 0.4×	3.6k 1.4×	3.9k 3.0×	157	15.0k
Tobias Feuchtinger Germany	35	2.0k 0.4×	1.5k 0.5×	1.5k 0.6×	973 0.4×	510 0.4×	119	4.0k
Mirjam H.M. Heemskerk Netherlands	44	3.0k 0.6×	4.2k 1.5×	788 0.3×	1.0k 0.4×	1.6k 1.2×	167	6.4k
Rimas J. Orentas United States	34	6.6k 1.3×	2.9k 1.0×	292 0.1×	2.0k 0.8×	2.2k 1.7×	120	8.2k
J.H. Frederik Falkenburg Netherlands	53	3.7k 0.8×	5.4k 1.9×	965 0.4×	1.4k 0.5×	1.8k 1.4×	280	9.1k
Brigitte Sénéchal United States	18	2.3k 0.5×	1.6k 0.6×	436 0.2×	631 0.3×	813 0.6×	43	4.0k

Countries citing papers authored by Ann M. Leen

Since Specialization

Citations

This map shows the geographic impact of Ann M. Leen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann M. Leen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann M. Leen more than expected).

Fields of papers citing papers by Ann M. Leen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann M. Leen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann M. Leen. The network helps show where Ann M. Leen may publish in the future.

Co-authorship network of co-authors of Ann M. Leen

This figure shows the co-authorship network connecting the top 25 collaborators of Ann M. Leen. A scholar is included among the top collaborators of Ann M. Leen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann M. Leen. Ann M. Leen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vasileiou, Spyridoula, et al.. (2024). Phenotypic and Functional Characterization of Posoleucel, a Multivirus-Specific T Cell Therapy for the Treatment and Prevention of Viral Infections in Immunocompromised Patients. Transplantation and Cellular Therapy. 30(2). S427–S428. 1 indexed citations

Dadwal, Sanjeet, Rajat Bansal, Michael W. Schuster, et al.. (2024). Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients. Blood Advances. 8(17). 4740–4750. 10 indexed citations

Shafer, Paul, Maksim Mamonkin, LaQuisa Hill, et al.. (2024). Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 143(17). 1726–1737. 9 indexed citations

Shafer, Paul, Mae Woods, Jong Min Choi, et al.. (2024). Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing. Cytotherapy. 26(3). 266–275. 1 indexed citations

Kuvalekar, Manik, et al.. (2023). T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy. British Journal of Haematology. 202(4). 874–878. 6 indexed citations

Pfeiffer, Thomas, Ifigeneia Tzannou, Meng-Fen Wu, et al.. (2023). Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clinical Cancer Research. 29(2). 324–330. 49 indexed citations

Bajgain, Pradip, et al.. (2022). Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand–Expressing Solid Tumors. Cancer Immunology Research. 10(11). 1370–1385. 9 indexed citations

Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2021). Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19. Transplantation and Cellular Therapy. 27(3). S348–S349. 3 indexed citations

Pfeiffer, Thomas, Ifigeneia Tzannou, Swati Naik, et al.. (2021). Allogeneic, Off-the-Shelf Multi-Virus Specific T-Lymphocytes for the Treatment of Virus-Associated Hemorrhagic Cystitis in the Post-HSCT Setting. Transplantation and Cellular Therapy. 27(3). S91–S92. 1 indexed citations

10.

Nalawade, Saisha, Paul Shafer, Pradip Bajgain, et al.. (2021). Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. Journal for ImmunoTherapy of Cancer. 9(11). e003237–e003237. 56 indexed citations

11.

Sukumaran, Sujita, Norihiro Watanabe, Pradip Bajgain, et al.. (2018). Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discovery. 8(8). 972–987. 106 indexed citations

12.

Arasaratnam, Reuben J., Ifigeneia Tzannou, Paibel Aguayo‐Hiraldo, et al.. (2018). Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. American Journal of Transplantation. 18(9). 2238–2249. 8 indexed citations

13.

Tanaka, Miyuki, Haruko Tashiro, Bilal Omer, et al.. (2017). Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells. Clinical Cancer Research. 23(14). 3499–3509. 81 indexed citations

14.

Lulla, Premal, Swati Naik, Ifigeneia Tzannou, et al.. (2017). Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT. Blood. 130. 164–164. 1 indexed citations

15.

Ngo, Minhtran, Jun Ando, Ann M. Leen, et al.. (2014). Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity. Journal of Immunotherapy. 37(4). 193–203. 40 indexed citations

16.

Leen, Ann M., Catherine M. Bollard, Adam Mendizabal, et al.. (2013). Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 121(26). 5113–5123. 392 indexed citations

17.

Weber, Gerrit, Ignazio Caruana, Rayne H. Rouce, et al.. (2013). Generation of Tumor Antigen-Specific T Cell Lines from Pediatric Patients with Acute Lymphoblastic Leukemia—Implications for Immunotherapy. Clinical Cancer Research. 19(18). 5079–5091. 55 indexed citations

18.

Pesonen, Sari, Iulia Diaconu, Lotta Kangasniemi, et al.. (2012). Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients. Cancer Research. 72(7). 1621–1631. 107 indexed citations

19.

Cruz, Carolina Colli, Ulrike Gerdemann, Ann M. Leen, et al.. (2011). Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4. Clinical Cancer Research. 17(22). 7058–7066. 56 indexed citations

20.

Chévez‐Barrios, Patricia, Ann M. Leen, Murali Chintagumpala, et al.. (2005). Immune Response of Retinoblastoma Treated With Suicide Gene Therapy Using Adenoviral–Mediated Delivery of Thymidine Kinase Followed by Ganciclovir. Investigative Ophthalmology & Visual Science. 46(13). 5218–5218. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact